Millions of patients undergo inpatient surgery each year and have anesthesia, medications and fluids administered through intravenous (IV) therapy. Peripheral IVs (PIVs) are the most common invasive medical procedure, and more than 300 million IV catheters are sold in the U.S. every year.*

But according to current medical reports, more than 20% of IVs fail because of infiltration.*

Patients receiving IV therapy during surgery can be at risk for IV complications because of the length of surgery and the limited visibility of the IV site during a procedure. Every one of these PIV complications is a medication dosing and delivery error that can cause additional patient harm, prolong hospital stays, or increase health care expenses. Any one of these may result in significant legal risk and reputation damage for healthcare providers. Prompt identification of infiltrations reduces these risks to both adult and pediatric patients undergoing peripheral IV therapy.

A continuous monitoring device for peripheral IVs is the new and next step for minimizing this potential for patient harm. Immediate warning of infiltrations reduces the risk of injury to every patient with a peripheral IV.

Because this kind of device is always watching the IV site, it gives clinicians a reasonable and less intrusive alternative a central line, and significantly improves the security of a standard unmonitored PIV.

*Helm, R. E., Klausner, J.D., Klemperer, J.D., Flint, L.M., and Huang, E. (2015). “Accepted but Unacceptable: Peripheral IV Catheter Failure.” Journal of Infusion Nursing, 38(3), 189-203.